These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 19027288

  • 1. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
    Poincloux L, Durando X, Seitz JF, Thivat E, Bardou VJ, Giovannini MH, Parriaux D, Barriere N, Giovannini M, Delpero JR, Monges G.
    Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.
    Sinicrope FA, Hart J, Michelassi F, Lee JJ.
    Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900
    [Abstract] [Full Text] [Related]

  • 3. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
    Schiller AB, Clark WS, Cotsonis G, Lawson D, DeRose PB, Cohen C.
    Cytometry; 2002 Aug 15; 50(4):203-9. PubMed ID: 12210599
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB, Ehara H, Gotoh T, Nakano M, Yokoi S, Deguchi T, Hirose Y.
    Urology; 2007 May 15; 69(5):843-8. PubMed ID: 17482919
    [Abstract] [Full Text] [Related]

  • 5. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M, Li JY, Zhao AL, Gu J.
    Oncology; 2007 May 15; 73(1-2):52-7. PubMed ID: 18334831
    [Abstract] [Full Text] [Related]

  • 6. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A.
    BMC Cancer; 2007 Aug 10; 7():156. PubMed ID: 17692120
    [Abstract] [Full Text] [Related]

  • 7. Cdc2 as prognostic marker in stage UICC II colon carcinomas.
    Meyer A, Merkel S, Brückl W, Schellerer V, Schildberg C, Campean V, Hohenberger W, Croner RS.
    Eur J Cancer; 2009 May 10; 45(8):1466-73. PubMed ID: 19223178
    [Abstract] [Full Text] [Related]

  • 8. [Comparative study of P 53, Bcl-2, and C-erbB-2 expression in low-grade papillary bladder tumors].
    Ramos Soler D, Navarro Fos S, Villamón Fort R, Gil Salom M, Llombart Bosch A.
    Arch Esp Urol; 2003 Apr 10; 56(3):277-85. PubMed ID: 12768988
    [Abstract] [Full Text] [Related]

  • 9. Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy.
    Yang Q, Moran MS, Haffty BG.
    Breast Cancer Res Treat; 2009 May 10; 115(2):343-8. PubMed ID: 18516673
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H, Zizi-Sermpetzoglou A, Elemenoglou I, Papatheofanis I, Peros G, Athanasas G, Panousopoulos D.
    Pol J Pathol; 2006 May 10; 57(3):149-59. PubMed ID: 17219742
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery.
    Galizia G, Lieto E, Ferraraccio F, De Vita F, Castellano P, Orditura M, Imperatore V, La Mura A, La Manna G, Pinto M, Catalano G, Pignatelli C, Ciardiello F.
    Ann Surg Oncol; 2006 Jun 10; 13(6):823-35. PubMed ID: 16614884
    [Abstract] [Full Text] [Related]

  • 12. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC, Kardamakis D, Tsiamalos P, Liava A, Tzelepi V, Vassiliou V, Petsas T, Vagenas K, Zolota V, Scopa CD.
    Anticancer Res; 2009 Feb 10; 29(2):703-9. PubMed ID: 19331225
    [Abstract] [Full Text] [Related]

  • 13. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
    Nakamura M, Miyamoto S, Maeda H, Zhang SC, Sangai T, Ishii G, Hasebe T, Endoh Y, Saito N, Asaka M, Ochiai A.
    Clin Cancer Res; 2004 Dec 15; 10(24):8434-41. PubMed ID: 15623623
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K, Kawashiri S, Yoshizawa K, Kitahara H, Yamamoto E.
    J Oral Pathol Med; 2008 Jul 15; 37(6):364-71. PubMed ID: 18410312
    [Abstract] [Full Text] [Related]

  • 15. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
    Yaren A, Oztop I, Kargi A, Ulukus C, Onen A, Sanli A, Binicier O, Yilmaz U, Alakavuklar M.
    Int J Clin Pract; 2006 Jun 15; 60(6):675-82. PubMed ID: 16805752
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of oncogenesis in colon versus rectal cancer.
    Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RA, Moriya Y, van de Velde CJ, van Krieken JH.
    J Pathol; 2001 Sep 15; 195(2):171-8. PubMed ID: 11592095
    [Abstract] [Full Text] [Related]

  • 17. Correlation between colorectal cancer Bcl-2 expression and tumour clinicopathological variables.
    Guzińska-Ustymowicz K, Famulski W, Stasiak-Barmuta A, Zalewski B, Sulkowska M.
    Rocz Akad Med Bialymst; 2002 Sep 15; 47():246-53. PubMed ID: 12533967
    [Abstract] [Full Text] [Related]

  • 18. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.
    Krajewska M, Kim H, Kim C, Kang H, Welsh K, Matsuzawa S, Tsukamoto M, Thomas RG, Assa-Munt N, Piao Z, Suzuki K, Perucho M, Krajewski S, Reed JC.
    Clin Cancer Res; 2005 Aug 01; 11(15):5451-61. PubMed ID: 16061861
    [Abstract] [Full Text] [Related]

  • 19. Clinical implications of fibroblast activation protein in patients with colon cancer.
    Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, Chen WT, Cheng JD.
    Clin Cancer Res; 2007 Mar 15; 13(6):1736-41. PubMed ID: 17363526
    [Abstract] [Full Text] [Related]

  • 20. Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer.
    Zlobec I, Höller S, Tornillo L, Terracciano L, Lugli A.
    Dis Colon Rectum; 2009 Jun 15; 52(6):1114-21. PubMed ID: 19581855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.